Suppr超能文献

肝移植后死亡率的病因和风险因素的演变:NIDDK 长期随访研究的结果。

Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, MN, USA.

出版信息

Am J Transplant. 2010 Jun;10(6):1420-7. doi: 10.1111/j.1600-6143.2010.03126.x. Epub 2010 May 10.

Abstract

Although mortality rates following liver transplantation (LT) are well described, there is a lack of detailed, prospective studies determining patterns of and risk factors for long-term mortality. We analyzed the multicenter, prospectively obtained The National Institute of Diabetes and Digestive and Kidney Diseases LT Database of 798 transplant recipients from 1990 to 1994 (follow-up 2003). Overall, 327 recipients died. Causes of death >1 year: 28% hepatic, 22% malignancy, 11% cardiovascular, 9% infection, 6% renal failure. Renal-related death increased dramatically over time. Risk factors for death >1 year (univariate): male gender, age/decade, pre-LT diabetes, post-LT diabetes, post-LT hypertension, post-LT renal insufficiency, retransplantation >1 year, pre-LT malignancy, alcoholic disease (ALD) and metabolic liver disease, with similar risks noted for death >5 years. Hepatitis C, retransplantation, post-LT diabetes, hypertension and renal insufficiency were significant risk factors for liver-related death. Cardiac deaths associated with age, male gender, ALD, cryptogenic disease, pre-LT hypertension and post-LT renal insufficiency. In summary, the leading causes of late deaths after transplant were graft failure, malignancy, cardiovascular disease and renal failure. Older age, diabetes and renal insufficiency identified patients at highest risk of poor survival overall. Diligent management of modifiable post-LT factors including diabetes, hypertension and renal insufficiency may impact long-term mortality.

摘要

尽管肝移植(LT)后的死亡率已有很好的描述,但缺乏详细的前瞻性研究来确定长期死亡率的模式和危险因素。我们分析了 1990 年至 1994 年期间来自 1990 年至 1994 年的国家糖尿病、消化和肾脏疾病 LT 数据库(随访至 2003 年)的多中心、前瞻性获得的 798 例移植受者。总体而言,有 327 例受者死亡。1 年以上死因:28%为肝性,22%为恶性肿瘤,11%为心血管,9%为感染,6%为肾功能衰竭。肾功能相关死亡随时间显著增加。1 年以上死亡的危险因素(单因素):男性,年龄/十年,LT 前糖尿病,LT 后糖尿病,LT 后高血压,LT 后肾功能不全,再移植>1 年,LT 前恶性肿瘤,酒精性疾病(ALD)和代谢性肝病,5 年以上死亡的风险相似。丙型肝炎、再移植、LT 后糖尿病、高血压和肾功能不全是与肝相关死亡的显著危险因素。与年龄、男性、ALD、隐源性疾病、LT 前高血压和 LT 后肾功能不全相关的心脏死亡。总之,移植后晚期死亡的主要原因是移植物衰竭、恶性肿瘤、心血管疾病和肾功能衰竭。年龄较大、糖尿病和肾功能不全使患者总体生存率最高的风险增加。对 LT 后可改变的因素(包括糖尿病、高血压和肾功能不全)进行严格管理可能会影响长期死亡率。

相似文献

3
Analysis of adult 20-year survivors after liver transplantation.肝移植术后成年20年幸存者的分析。
Hepatol Int. 2015 Jul;9(3):461-70. doi: 10.1007/s12072-014-9577-x. Epub 2014 Sep 18.

引用本文的文献

5
Insights and perspectives: EUS in post-liver transplantation care.见解与观点:内镜超声在肝移植术后护理中的应用
Endosc Ultrasound. 2024 Sep-Oct;13(5):283-286. doi: 10.1097/eus.0000000000000084. Epub 2024 Nov 5.
8
Side Effects of Immunosuppressant Drugs After Liver Transplant.肝移植后免疫抑制药物的副作用
Pharmaceuticals (Basel). 2025 Feb 27;18(3):342. doi: 10.3390/ph18030342.

本文引用的文献

3
The hepatitis C virus-associated dysmetabolic syndrome.
Hepatology. 2008 Sep;48(3):1018-9; author reply 1019. doi: 10.1002/hep.22425.
7
Long-term results after liver transplantation.肝移植后的长期结果。
Transpl Int. 2008 Mar;21(3):234-46. doi: 10.1111/j.1432-2277.2007.00596.x. Epub 2007 Nov 21.
9
The burden of new-onset diabetes mellitus after transplantation.移植后新发糖尿病的负担。
Clin Transplant. 2006 Nov-Dec;20(6):755-61. doi: 10.1111/j.1399-0012.2006.00565.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验